{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:38:33Z","timestamp":1781077113338,"version":"3.54.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1053\/j.seminhematol.2026.03.012","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T02:58:08Z","timestamp":1775098688000},"page":"479-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and management of hematologic malignancies in the context of telomere biology disorders"],"prefix":"10.1053","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4883-3023","authenticated-orcid":false,"given":"Alejandro","family":"Ferrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal M.","family":"Patnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.012_bib0001","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41408-021-00564-7","article-title":"Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths","volume":"11","author":"Mangaonkar","year":"2021","journal-title":"Blood Cancer J"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.03.012_bib0002","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.mayocp.2018.05.015","article-title":"Clinical correlates and treatment outcomes for patients with short telomere syndromes","volume":"93","author":"Mangaonkar","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.03.012_bib0003","article-title":"Telomeres and human disease","volume":"17","author":"Savage","year":"2025","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.03.012_bib0004","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1182\/blood.2021013523","article-title":"Disease progression and clinical outcomes in telomere biology disorders","volume":"139","author":"Niewisch","year":"2022","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2026.03.012_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev-genom-010422-091101","article-title":"The role of telomeres in human disease","volume":"23","author":"Armanios","year":"2022","journal-title":"Ann Rev Genom Human Genet"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.012_bib0006","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000540109","article-title":"Inherited telomere biology disorders: pathophysiology, clinical presentation, diagnostics, and treatment","volume":"51","author":"Rolles","year":"2024","journal-title":"Transfus Med Hemother"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.03.012_bib0007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3324\/haematol.2017.178111","article-title":"Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up","volume":"103","author":"Alter","year":"2018","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2026.03.012_bib0008","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.gde.2020.02.019","article-title":"Cancer and myeloid clonal evolution in the short telomere syndromes","volume":"60","author":"Schratz","year":"2020","journal-title":"Curr Opin Genet Dev"},{"issue":"20","key":"10.1053\/j.seminhematol.2026.03.012_bib0009","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1053\/j.seminhematol.2026.03.012_bib0010","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood.2024025023","article-title":"Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations","volume":"144","author":"Gutierrez-Rodrigues","year":"2024","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.03.012_bib0011","doi-asserted-by":"crossref","first-page":"E357","DOI":"10.1002\/ajh.27086","article-title":"Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants","volume":"98","author":"Ferrer","year":"2023","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.03.012_bib0012","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181659","article-title":"ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders","volume":"135","author":"Sande","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2026.03.012_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107076","article-title":"Clonal hematopoiesis: origins and determinants of evolution","volume":"129","author":"Mendez","year":"2023","journal-title":"Leuk Res"},{"issue":"6485","key":"10.1053\/j.seminhematol.2026.03.012_bib0014","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.aay9333","article-title":"The evolutionary dynamics and fitness landscape of clonal hematopoiesis","volume":"367","author":"Watson","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.012_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41408-021-00439-x","article-title":"Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study","volume":"11","author":"Xie","year":"2021","journal-title":"Blood Cancer J"},{"issue":"26","key":"10.1053\/j.seminhematol.2026.03.012_bib0016","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1053\/j.seminhematol.2026.03.012_bib0017","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa1409405","article-title":"Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence","volume":"371","author":"Genovese","year":"2014","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1053\/j.seminhematol.2026.03.012_bib0018","first-page":"7047","article-title":"Telomere dysfunction results in enhanced organismal sensitivity to the alkylating agent N-methyl-N-nitrosourea","volume":"63","author":"Gonzalez-Suarez","year":"2003","journal-title":"Cancer Res"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.03.012_bib0019","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.192.11.1625","article-title":"Short telomeres result in organismal hypersensitivity to ionizing radiation in mammals","volume":"192","author":"Goytisolo","year":"2000","journal-title":"J Exp Med"},{"issue":"21","key":"10.1053\/j.seminhematol.2026.03.012_bib0020","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1182\/blood-2017-05-781799","article-title":"Inherited bone marrow failure syndromes: considerations pre- and posttransplant","volume":"130","author":"Alter","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.012_bib0021","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.rdc.2020.03.001","article-title":"Autoimmunity, clonal hematopoiesis, and myeloid neoplasms","volume":"46","author":"Bekele","year":"2020","journal-title":"Rheum Dis Clin North Am"},{"issue":"7913","key":"10.1053\/j.seminhematol.2026.03.012_bib0022","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","article-title":"The longitudinal dynamics and natural history of clonal haematopoiesis","volume":"606","author":"Fabre","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.seminhematol.2026.03.012_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2022.106787","article-title":"Clonal hematopoiesis: molecular and clinical implications","volume":"113","author":"Kusne","year":"2022","journal-title":"Leuk Res"},{"issue":"7913","key":"10.1053\/j.seminhematol.2026.03.012_bib0024","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41586-022-04786-y","article-title":"Clonal dynamics of haematopoiesis across the human lifespan","volume":"606","author":"Mitchell","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.012_bib0025","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1073\/pnas.051609898","article-title":"Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells","volume":"98","author":"Gregory","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2\u20133","key":"10.1053\/j.seminhematol.2026.03.012_bib0026","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000069805","article-title":"Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction","volume":"98","author":"Gross","year":"2002","journal-title":"Cytogenet Genome Res"},{"issue":"Supplement 1","key":"10.1053\/j.seminhematol.2026.03.012_bib0027","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1182\/blood-2021-151199","article-title":"Clonal hematopoiesis in telomere biology disorders associates with the underlying germline defect and somatic mutations in POT1, PPM1D, and TERT promoter","volume":"138","author":"Gutierrez-Rodrigues","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.012_bib0028","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1172\/JCI91161","article-title":"Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations","volume":"127","author":"Maryoung","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2026.03.012_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2023.107356","article-title":"Clonal hematopoiesis of indeterminate potential: overmedicalization or context dependant relevance?","volume":"133","author":"Patnaik","year":"2023","journal-title":"Leuk Res"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.03.012_bib0030","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1182\/bloodadvances.2025018031","article-title":"Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias","volume":"10","author":"Badar","year":"2026","journal-title":"Blood Adv"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.03.012_bib0031","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/GIM.0b013e3181f415b5","article-title":"The genetics and clinical manifestations of telomere biology disorders","volume":"12","author":"Savage","year":"2010","journal-title":"Genet Med"},{"issue":"24","key":"10.1053\/j.seminhematol.2026.03.012_bib0032","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1182\/blood.2022015790","article-title":"Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages","volume":"140","author":"Feurstein","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.03.012_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50111","article-title":"Genotype and associated cancer risk in individuals with telomere biology disorders","volume":"7","author":"Niewisch","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.012_bib0034","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V97.4.895","article-title":"Telomere length in leukocyte subpopulations of patients with aplastic anemia","volume":"97","author":"Br\u00fcmmendorf","year":"2001","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.03.012_bib0035","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1720427115","article-title":"Diagnostic utility of telomere length testing in a hospital-based setting","volume":"115","author":"Alder","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.03.012_bib0036","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.mayocp.2019.04.007","article-title":"Clinical applications and utility of a precision medicine approach for patients with unexplained cytopenias","volume":"94","author":"Mangaonkar","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.012_bib0037","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11899-022-00662-8","article-title":"Patnaik MM. Clonal hematopoiesis and myeloid neoplasms in the context of telomere biology disorders","volume":"17","author":"Ferrer","year":"2022","journal-title":"Curr Hematol Malig Rep"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.03.012_bib0038","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3324\/haematol.2016.145821","article-title":"Response to treatment with azacitidine in children with advanced myelodysplastic syndrome prior to hematopoietic stem cell transplantation","volume":"101","author":"Waespe","year":"2016","journal-title":"Haematologica"},{"issue":"13","key":"10.1053\/j.seminhematol.2026.03.012_bib0039","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2016-06-724500","article-title":"Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel","volume":"129","author":"de Witte","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.03.012_bib0040","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.03.012_bib0041","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"10.1053\/j.seminhematol.2026.03.012_bib0042","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1182\/blood.2020005397","article-title":"Short telomere length predicts nonrelapse mortality after stem cell transplantation for myelodysplastic syndrome","volume":"136","author":"Myllymaki","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.03.012_bib0043","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.mayocp.2018.08.013","article-title":"Short telomere syndromes, biological aging, and hematopoietic stem cell transplantation","volume":"93","author":"Testori","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.seminhematol.2026.03.012_bib0044","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.55438","article-title":"Mechanisms of nucleotide selection by telomerase","volume":"9","author":"Schaich","year":"2020","journal-title":"Elife"},{"issue":"6","key":"10.1053\/j.seminhematol.2026.03.012_bib0045","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201797953","article-title":"A single nucleotide incorporation step limits human telomerase repeat addition activity","volume":"37","author":"Chen","year":"2018","journal-title":"EMBO J"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.012_bib0046","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41588-023-01339-5","article-title":"Thymidine nucleotide metabolism controls human telomere length","volume":"55","author":"Mannherz","year":"2023","journal-title":"Nat Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.012_bib0047","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s13311-013-0177-6","article-title":"Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options","volume":"10","author":"El-Hattab","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"7290","key":"10.1053\/j.seminhematol.2026.03.012_bib0048","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nature08882","article-title":"Zscan4 regulates telomere elongation and genomic stability in ES cells","volume":"464","author":"Zalzman","year":"2010","journal-title":"Nature"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.03.012_bib0049","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.celrep.2017.07.070","article-title":"Zscan4 Inhibits maintenance DNA methylation to facilitate telomere elongation in mouse embryonic stem cells","volume":"20","author":"Dan","year":"2017","journal-title":"Cell Rep"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.03.012_bib0050","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400252","article-title":"Clinical use of ZSCAN4 for telomere elongation in hematopoietic stem cells","volume":"4","author":"Myers","year":"2025","journal-title":"NEJM Evid"},{"issue":"6963","key":"10.1053\/j.seminhematol.2026.03.012_bib0051","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nature02118","article-title":"A DNA damage checkpoint response in telomere-initiated senescence","volume":"426","author":"d'Adda di Fagagna","year":"2003","journal-title":"Nature"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.03.012_bib0052","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ncb2466","article-title":"Telomeric DNA damage is irreparable and causes persistent DNA-damage-response activation","volume":"14","author":"Fumagalli","year":"2012","journal-title":"Nat Cell Biol"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.012_bib0053","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41580-020-00314-w","article-title":"Cellular senescence in ageing: from mechanisms to therapeutic opportunities","volume":"22","author":"Di Micco","year":"2021","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.03.012_bib0054","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","article-title":"Telomere dysfunction in ageing and age-related diseases","volume":"24","author":"Rossiello","year":"2022","journal-title":"Nat Cell Biol"},{"issue":"21","key":"10.1053\/j.seminhematol.2026.03.012_bib0055","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1038\/s44318-025-00521-1","article-title":"Telomeric DNA damage response mediates neurotoxicity of Abeta42 oligomers in Alzheimer's disease","volume":"44","author":"Sepe","year":"2025","journal-title":"EMBO J"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:54:27Z","timestamp":1781027667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196326000259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0037196326000259"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.03.012","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of hematologic malignancies in the context of telomere biology disorders","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}